Pricing and Reimbursement Policies in Estonian Pharmaceutical Market
The case study provides an overview of the main features of the pharmaceuticals pricing andreimbursement policies in Estonia, based on a review of regulations and literature, and data analysis. The first chapter of the report provides background in...
| Main Author: | |
|---|---|
| Language: | English |
| Published: |
World Bank, Washington, DC
2020
|
| Subjects: | |
| Online Access: | http://documents.worldbank.org/curated/en/209011593100198695/Pricing-and-reimbursement-policies-in-Estonian-pharmaceutical-market http://hdl.handle.net/10986/34189 |
| Summary: | The case study provides an overview of
the main features of the pharmaceuticals pricing
andreimbursement policies in Estonia, based on a review of
regulations and literature, and data analysis. The first
chapter of the report provides background information on the
Estonian health system context and overall description of
the pharmaceutical sector. The second chapter focuses on the
pricing policies used for the retail and hospital sector
medicines, while outlining the impact of current policies.
The third chapter takes a closer look into the reimbursement
policies for outpatient and inpatient medicines. Finally,
some conclusions from the case study are provided. |
|---|